Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT00165256
PHASE2

Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast

Sponsor: Dana-Farber Cancer Institute

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine if wide excision (surgical removal) alone is adequate treatment for small, grade 1 or 2 ductal carcinoma in situ (DCIS) of the breast.

Official title: Wide Excision Alone for DCIS-Grades 1 and 2

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

158

Start Date

1995-05

Completion Date

2027-12

Last Updated

2025-12-29

Healthy Volunteers

No

Interventions

OTHER

Observation

Wide excision of DCIS and a minimum of 1cm histologically negative margin of breast tissue

Locations (2)

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

Massachusetts General Hospital

Boston, Massachusetts, United States